Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):1–14. doi: 10.3322/caac.21660.
   Web of Science ®Google Scholar
• Hanley CJ, Thomas GJ. Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives. Oncotarget. 2021;12(14):1427–1433. doi: 10.18632/oncotarget.27936.
   PubMedGoogle Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423–1437. doi: 10.1038/nm.3394.
   PubMed Web of Science ®Google Scholar
• Mhaidly R, Mechta-Grigoriou F. Fibroblast heterogeneity in tumor micro-environment: role in immunosuppression and new therapies. Semin Immunol. 2020;48:101417. doi: 10.1016/j.smim.2020.101417.
   PubMed Web of Science ®Google Scholar
• Costa A, Kieffer Y, Scholer-Dahirel A, et al. Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell. 2018;33(3):463–479 e10. doi: 10.1016/j.ccell.2018.01.011.
   PubMed Web of Science ®Google Scholar
• Musa M. Single-cell analysis on stromal fibroblasts in the microenvironment of solid tumours. Adv Med Sci. 2020;65(1):163–169. doi: 10.1016/j.advms.2019.12.001.
   PubMed Web of Science ®Google Scholar
• Lappano R, Rigiracciolo DC, Belfiore A, et al. Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets. Expert Opin Ther Targets. 2020;24(6):559–572. doi: 10.1080/14728222.2020.1751819.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang L-G, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi: 10.1089/omi.2011.0118.
   PubMed Web of Science ®Google Scholar
• Shekhar MPV, Santner S, Carolin KA, et al. Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity. Am J Pathol. 2007;170(5):1546–1560. doi: 10.2353/ajpath.2007.061004.
   PubMed Web of Science ®Google Scholar
• Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005;121(3):335–348. doi: 10.1016/j.cell.2005.02.034.
   PubMed Web of Science ®Google Scholar
• Park D, Sahai E, Rullan A. SnapShot: cancer-associated fibroblasts. Cell. 2020;181(2):486–486.e1. doi: 10.1016/j.cell.2020.03.013.
   PubMed Web of Science ®Google Scholar
• De Jaeghere EA, Denys HG, De Wever O. Fibroblasts fuel immune escape in the tumor microenvironment. Trends Cancer. 2019;5(11):704–723. doi: 10.1016/j.trecan.2019.09.009.
   PubMed Web of Science ®Google Scholar
• Kieffer Y, Hocine HR, Gentric G, et al. Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer. Cancer Discov. 2020;10(9):1330–1351. doi: 10.1158/2159-8290.CD-19-1384.
   PubMed Web of Science ®Google Scholar
• Öhlund D, Handly-Santana A, Biffi G, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214(3):579–596. doi: 10.1084/jem.20162024.
   PubMed Web of Science ®Google Scholar
• Mounir M, Lucchetta M, Silva TC, et al. New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx. PLOS Comput Biol. 2019;15(3):e1006701. doi: 10.1371/journal.pcbi.1006701.
   PubMed Web of Science ®Google Scholar
• Silva TC, Colaprico A, Olsen C, et al. TCGA workflow: analyze cancer genomics and epigenomics data using bioconductor packages. F1000Res. 2016;5:1542. doi: 10.12688/f1000research.8923.1.
   PubMedGoogle Scholar
• Zheng S, Zou Y, Tang Y, et al. Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer. Oncoimmunology. 2022;11(1):e2020984-2. doi: 10.1080/2162402X.2021.2020984.
   Web of Science ®Google Scholar
• Carvalho I, Milanezi F, Martins A, et al. Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression. Breast Cancer Res. 2005;7(5):R788–95. doi: 10.1186/bcr1304.
   PubMed Web of Science ®Google Scholar
• Paulsson J, Rydén L, Strell C, et al. High expression of stromal PDGFRbeta is associated with reduced benefit of tamoxifen in breast cancer. J Pathol Clin Res. 2017;3(1):38–43. doi: 10.1002/cjp2.56.
   PubMedGoogle Scholar
• Frings O, Augsten M, Tobin NP, et al. Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signaling. Am J Pathol. 2013;182(6):2037–2047. doi: 10.1016/j.ajpath.2013.02.018.
   PubMed Web of Science ®Google Scholar
• Sahai E, Astsaturov I, Cukierman E, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174–186. doi: 10.1038/s41568-019-0238-1.
   PubMed Web of Science ®Google Scholar
• Gascard P, Tlsty TD. Carcinoma-associated fibroblasts: orchestrating the composition of malignancy. Genes Dev. 2016;30(9):1002–1019. doi: 10.1101/gad.279737.116.
   PubMed Web of Science ®Google Scholar
• Gentric G, Mieulet V, Mechta-Grigoriou F. Heterogeneity in cancer metabolism: new concepts in an old field. Antioxid Redox Signal. 2017;26(9):462–485. doi: 10.1089/ars.2016.6750.
   PubMed Web of Science ®Google Scholar
• Lakins MA, Ghorani E, Munir H, et al. Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T cells to protect tumour cells. Nat Commun. 2018;9(1):948. doi: 10.1038/s41467-018-03347-0.
   PubMed Web of Science ®Google Scholar
• Hsu Y-L, Hung J-Y, Chiang S-Y, et al. Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis. Oncotarget. 2016;7(19):27584–27598. doi: 10.18632/oncotarget.8488.
   PubMedGoogle Scholar
• Cheng J-T, Deng Y-N, Yi H-M, et al. Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation. Oncogenesis. 2016;5(2):e198–e198. doi: 10.1038/oncsis.2016.7.
   PubMedGoogle Scholar
• Xiang H, Ramil CP, Hai J, et al. Cancer-Associated fibroblasts promote immunosuppression by inducing ROS-Generating monocytic MDSCs in lung squamous cell carcinoma. Cancer Immunol Res. 2020;8(4):436–450. doi: 10.1158/2326-6066.CIR-19-0507.
   PubMed Web of Science ®Google Scholar
• Ding J-H, Xiao Y, Zhao S, et al. Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer. Mol Ther Oncolytics. 2022;24:624–635. doi: 10.1016/j.omto.2022.02.003.
   PubMed Web of Science ®Google Scholar
• Salmon H, Franciszkiewicz K, Damotte D, et al. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Invest. 2012;122(3):899–910. doi: 10.1172/JCI45817.
   PubMed Web of Science ®Google Scholar
• Murdamoothoo D, Sun Z, Yilmaz A, et al. Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression. EMBO Mol Med. 2021;13(6):e13270. doi: 10.15252/emmm.202013270.
   PubMed Web of Science ®Google Scholar
• Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, et al. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11(1):5120. doi: 10.1038/s41467-020-18794-x.
   PubMed Web of Science ®Google Scholar
• Pang X-J, Liu X-J, Liu Y, et al. Drug discovery targeting focal adhesion kinase (FAK) as a promising cancer therapy. Molecules. 2021;26(14):4250. doi: 10.3390/molecules26144250.
   PubMed Web of Science ®Google Scholar
• Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15(12):1243–1253. doi: 10.15252/embr.201439246.
   PubMed Web of Science ®Google Scholar
• Jiang H, Hegde S, Knolhoff BL, et al. Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy. Nat Med. 2016;22(8):851–860. doi: 10.1038/nm.4123.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhou J, Zhang J, et al. Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5. Int J Cancer. 2019;145(7):1946–1957. doi: 10.1002/ijc.32278.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Xu B, Hu F, et al. Tenascin C promotes glioma cell malignant behavior and inhibits chemosensitivity to paclitaxel via activation of the PI3K/AKT signaling pathway. J Mol Neurosci. 2021;71(8):1636–1647. doi: 10.1007/s12031-021-01832-8.
   PubMed Web of Science ®Google Scholar
• Katoh D, Kozuka Y, Noro A, et al. Tenascin-C induces phenotypic changes in fibroblasts to myofibroblasts with high contractility through the integrin alphavbeta1/transforming growth factor beta/SMAD signaling axis in human breast cancer. Am J Pathol. 2020;190(10):2123–2135. doi: 10.1016/j.ajpath.2020.06.008.
   PubMed Web of Science ®Google Scholar
• Oskarsson T, Acharyya S, Zhang XH-F, et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med. 2011;17(7):867–874. doi: 10.1038/nm.2379.
   PubMed Web of Science ®Google Scholar
• Chong HC, Tan CK, Huang R-L, et al. Matricellular proteins: a sticky affair with cancers. J Oncol. 2012;2012:351089–351017. doi: 10.1155/2012/351089.
   PubMedGoogle Scholar